Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker UPB
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Aaron Deykin Chief Medical Officer | UPB Upstream Bio, Inc. | Sale | 895 | $5.49 | $4,914 Sale | Form 4 ↗ |
| Sep 16, 2026 | Everett Rand Sutherland Chief Executive Officer, Director | UPB Upstream Bio, Inc. | Sale | 2,095 | $5.49 | $11.5K Sale | Form 4 ↗ |
| Sep 16, 2026 | Adam Houghton Chief Business Officer | UPB Upstream Bio, Inc. | Sale | 700 | $5.49 | $3,843 Sale | Form 4 ↗ |
| Sep 16, 2026 | Michael Gray CFO and COO | UPB Upstream Bio, Inc. | Sale | 853 | $5.49 | $4,683 Sale | Form 4 ↗ |
| Sep 16, 2026 | Allison Ambrose General Counsel | UPB Upstream Bio, Inc. | Sale | 485 | $5.49 | $2,663 Sale | Form 4 ↗ |
| Jun 16, 2026 | Michael Gray CFO and COO | UPB Upstream Bio, Inc. | Sale | 853 | $6.10 | $5,203 Sale | Form 4 ↗ |
| Jun 16, 2026 | Everett Rand Sutherland Chief Executive Officer, Director | UPB Upstream Bio, Inc. | Sale | 2,095 | $6.10 | $12.8K Sale | Form 4 ↗ |
| Jun 16, 2026 | Adam Houghton Chief Business Officer | UPB Upstream Bio, Inc. | Sale | 700 | $6.10 | $4,270 Sale | Form 4 ↗ |
| Jun 16, 2026 | Aaron Deykin Chief Medical Officer | UPB Upstream Bio, Inc. | Sale | 895 | $6.10 | $5,460 Sale | Form 4 ↗ |
| Jun 16, 2026 | Allison Ambrose General Counsel | UPB Upstream Bio, Inc. | Sale | 477 | $6.10 | $2,910 Sale | Form 4 ↗ |
| Mar 16, 2026 | Michael Gray CFO and COO | UPB Upstream Bio, Inc. | Sale | 852 | $9.29 | $7,915 Sale | Form 4 ↗ |
| Mar 16, 2026 | Aaron Deykin Chief Medical Officer | UPB Upstream Bio, Inc. | Sale | 894 | $9.29 | $8,305 Sale | Form 4 ↗ |
| Mar 16, 2026 | Everett Rand Sutherland Chief Executive Officer, Director | UPB Upstream Bio, Inc. | Sale | 2,093 | $9.29 | $19.4K Sale | Form 4 ↗ |
| Mar 16, 2026 | Allison Ambrose General Counsel | UPB Upstream Bio, Inc. | Sale | 475 | $9.29 | $4,413 Sale | Form 4 ↗ |
| Mar 16, 2026 | Adam Houghton Chief Business Officer | UPB Upstream Bio, Inc. | Sale | 699 | $9.29 | $6,494 Sale | Form 4 ↗ |
| Oct 15, 2024 | Access Industries Holdings LLC 10% owner | UPB Upstream Bio, Inc. | Buy | 1.18M | $17.00 | $20.0M Buy | Form 4 ↗ |
| Oct 15, 2024 | Erez Chimovits Director, 10% owner | UPB Upstream Bio, Inc. | Buy | 660,000 | $17.00 | $11.2M Buy | Form 4 ↗ |
| Oct 15, 2024 | Erez Chimovits Director, 10% owner | UPB Upstream Bio, Inc. | Buy | 165,000 | $17.00 | $2.8M Buy | Form 4 ↗ |
| Oct 15, 2024 | Orbimed Advisors LLC Director, 10% owner | UPB Upstream Bio, Inc. | Buy | 660,000 | $17.00 | $11.2M Buy | Form 4 ↗ |
| Oct 15, 2024 | Orbimed Advisors LLC Director, 10% owner | UPB Upstream Bio, Inc. | Buy | 165,000 | $17.00 | $2.8M Buy | Form 4 ↗ |
20 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances